{"id":"https://openalex.org/W2591560728","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4509","title":"Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial.","display_name":"Docetaxel (D) plus high-dose calcitriol versus D plus prednisone (P) for patients (Pts) with progressive castration-resistant prostate cancer (CRPC): Results from the phase III ASCENT2 trial.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2591560728","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4509","mag":"2591560728"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.4509","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4509","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.4509","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072850546","display_name":"Howard I. Scher","orcid":"https://orcid.org/0000-0002-6791-9324","observed_orcids":["https://orcid.org/0000-0002-6791-9324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. I. Scher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110324910","display_name":"K. N. Chi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. N. Chi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041610986","display_name":"Ronald de Wit","orcid":"https://orcid.org/0000-0002-1954-090X","observed_orcids":["https://orcid.org/0000-0002-1954-090X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. De Wit","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101685417","display_name":"William R. Berry","orcid":"https://orcid.org/0000-0001-9217-4902","observed_orcids":["https://orcid.org/0000-0001-9217-4902"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. R. Berry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068364488","display_name":"Peter Albers","orcid":"https://orcid.org/0000-0002-1747-9615","observed_orcids":["https://orcid.org/0000-0002-1747-9615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Albers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079534671","display_name":"Brian S. Henick","orcid":"https://orcid.org/0000-0003-2681-0805","observed_orcids":["https://orcid.org/0000-0003-2681-0805"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Henick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013339044","display_name":"Peter N. Venner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Venner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048118430","display_name":"Axel Heidenreich","orcid":"https://orcid.org/0000-0002-2511-3664","observed_orcids":["https://orcid.org/0000-0002-2511-3664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Heidenreich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052348131","display_name":"Luis Chu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Chu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031035765","display_name":"Glenn Heller","orcid":"https://orcid.org/0000-0001-9217-8348","observed_orcids":["https://orcid.org/0000-0001-9217-8348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Heller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"4509","last_page":"4509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9309999942779541},{"id":"https://openalex.org/keywords/1-25-dihydroxyvitamin-d3","display_name":"1,25-dihydroxyvitamin D3","score":0.8270000219345093},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9089999794960022},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9580000042915344},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.8759999871253967},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8330000042915344},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5619999766349792},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.49000000953674316},{"id":"https://openalex.org/keywords/early-trial-termination","display_name":"early trial termination","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9268421530723572},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6579916477203369},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6484146118164062},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5614726543426514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5516322255134583},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5476523637771606},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.5111721158027649},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45543891191482544},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.43950819969177246},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4243358075618744},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.37576553225517273},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35407596826553345},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.333554744720459},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.32805901765823364},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2868502140045166},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.4509","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.4509","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.4509","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2151063703","https://openalex.org/W2143289308","https://openalex.org/W2024368237","https://openalex.org/W4237399610","https://openalex.org/W2274103071","https://openalex.org/W10235104","https://openalex.org/W1991416414","https://openalex.org/W2943913786","https://openalex.org/W2319535221","https://openalex.org/W2121762104"],"abstract_inverted_index":{"4509":[0],"Background:":[1],"For":[2],"Pts":[3,121,210],"with":[4,17,53,202,211,219,249],"progressive":[5],"CRPC,":[6],"a":[7,87],"placebo-controlled":[8],"phase":[9,31],"II":[10],"study":[11,33,147,170,298],"suggested":[12],"that":[13],"combining":[14],"docetaxel":[15],"(D)":[16],"high-dose":[18],"calcitriol":[19],"(DN-101)":[20],"may":[21],"increase":[22],"survival":[23,174,204,252],"compared":[24],"to":[25,36,46,57,261,279,282],"D":[26,43,47,92,229,263,283],"alone.":[27],"A":[28],"randomized,":[29],"open-label":[30],"III":[32],"was":[34,103,123,141,149,175,200,231,247],"undertaken":[35],"compare":[37],"the":[38,108,117,135,139,220,235,254,266,271,289],"safety":[39],"and":[40,67,89,93,138,155,184,217],"efficacy":[41],"of":[42,76,146,209,224,292],"plus":[44,48],"DN-101":[45],"P.":[49],"Methods:":[50],"953":[51],"men":[52],"CRPC":[54],"were":[55,114,132,215],"randomized":[56],"ASCENT":[58,136,153,182,199,236,239,245,267,300],"arm":[59,82,237,291,299],"(45":[60],"\u03bc":[61],"g":[62],"DN-101,":[63],"36":[64],"mg/m2":[65,91],"D,":[66],"24":[68,94],"mg":[69,84,95],"dexamethasone":[70],"(DEX)":[71],"weekly":[72,262],"for":[73,120,152,158,181,190,196,228],"3":[74,98,285],"out":[75],"every":[77,97,284],"4":[78],"weeks)":[79],"or":[80,318,322],"control":[81,242,290],"(5":[83],"P":[85],"twice":[86],"day,":[88],"75":[90],"DEX":[96],"weeks).":[99],"The":[100,160,207],"primary":[101],"endpoint":[102],"overall":[104,173],"survival,":[105],"assessed":[106],"by":[107],"Kaplan-Meier":[109],"method.":[110],"Results:":[111],"Baseline":[112],"demographics":[113],"comparable":[115],"between":[116],"groups.":[118],"Median-follow-up":[119],"alive":[122],"11.7":[124],"months.":[125],"At":[126],"an":[127],"interim":[128],"analysis,":[129,166],"more":[130,232],"deaths":[131,163],"observed":[133],"in":[134,234,265,270,288,296],"arm,":[137,268],"trial":[140,274],"halted":[142],"early.":[143],"Median":[144,172],"duration":[145],"treatment":[148,246],"16.6":[150],"weeks":[151,157],"subjects":[154,183],"21.0":[156],"controls.":[159,191],"Table":[161],"shows":[162],"at":[164],"final":[165],"6":[167],"months":[168,177,186],"after":[169],"termination.":[171],"16.8":[176],"(95%":[178,187],"CI,":[179,188],"15.8\u201319.3)":[180],"19.9":[185],"18.6-22.7)":[189],"In":[192],"multivariate":[193],"analysis":[194],"adjusting":[195],"baseline":[197],"variables,":[198],"associated":[201,248],"shorter":[203,251],"(HR=1.33;":[205],"p=0.019).":[206],"proportions":[208],"adverse":[212],"events":[213],"(AEs)":[214],"similar,":[216],"consistent":[218],"known":[221],"side":[222],"effects":[223],"D.":[225],"Dose":[226],"modification":[227],"toxicity":[230],"frequent":[233],"(229":[238],"vs.":[240],"160":[241],"subjects).":[243],"Conclusions:":[244],"significantly":[250],"than":[253],"control.":[255],"This":[256],"difference":[257],"might":[258],"be":[259,280],"due":[260],"dosing":[264],"which":[269],"TAX":[272],"327":[273],"(NEJM":[275],"351:1502,":[276],"2004)":[277],"appeared":[278],"inferior":[281],"weeks,":[286],"as":[287],"this":[293],"study.":[294],"Deaths":[295],"each":[297],"n=477":[301],"Control":[302],"n=476":[303],"Disease-specific":[304],"142":[305],"(29.8%)":[306],"108":[307],"(22.7%)":[308],"Other":[309,332],"cause":[310],"32":[311],"(6.7%)":[312],"30":[313],"(6.3%)":[314],"Author":[315],"Disclosure":[316],"Employment":[317],"Leadership":[319],"Position":[320],"Consultant":[321],"Advisory":[323],"Role":[324],"Stock":[325],"Ownership":[326],"Honoraria":[327],"Research":[328],"Funding":[329],"Expert":[330],"Testimony":[331],"Remuneration":[333],"Novacea":[334,335]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-03T00:00:00"}